Diversified Trust’s Halozyme HALO Stock Holding History

Diversified Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,648	Closed	-$446K	–	676
2020 Q2	$446K	Buy	+16,648	New	+$376K	0.02%	280

Other funds holding HALO

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Diversified Trust's HALO Position: Q3 2020 in Review

Diversified Trust sold out of Halozyme (HALO) in Q3 2020, closing a stake of 16,648 shares — an estimated $446K sold.

Diversified Trust first reported a position in HALO in Q2 2020 and held it in 1 quarter. The position peaked at $446K in Q2 2020. 268 funds tracked by Wall St. Rank hold HALO as of Q3 2020.

Diversified Trust reported no remaining Halozyme position as of Q3 2020 after selling out during the quarter.
Diversified Trust sold 16,648 Halozyme shares in Q3 2020, an estimated $446K.
Diversified Trust first reported a position in Halozyme in Q2 2020 and held it in 1 quarter.
Diversified Trust's Halozyme position peaked at $446K in Q2 2020.
268 funds tracked by Wall St. Rank held Halozyme as of Q3 2020.

Based on Diversified Trust's 13F filing for Q3 2020, filed 15 Oct 2020.